FAQs: COVID-19 vaccinations for 12 to 15 year-olds

Who is giving the COVID-19 vaccine to healthy 12- to 15-year-olds?

Children and young people’s vaccinations have been carried out by school aged immunisation services (SAIS), provider organisations such as NHS community trusts who are contracted in local systems to provide routine immunisation services such as flu.

Along with vaccinations that took place at schools across mid and south Essex, some vaccination sites are also vaccinating children aged 12 to 15. You can book an appointment via the national booking service or can check the availability of walk-in clinics for 12 to 15 year olds near you on our walk in page. Please note walk in clinics are subject to change and a vaccinations cannot be guaranteed on the day of your attendance.

Should a child get an extra dose of the vaccine if they have had one already?

All 12 to 15 year olds are being offered two doses of the COVID-19 vaccine. The 2nd dose is available 12 weeks after the 1st dose. Please note that if a child aged 12 to 15 contracts COVID-19 after the 1st dose, then they need to wait 12 weeks after the infection rather than 12 weeks after the 1st dose.

A relatively small proportion of children in this age group are eligible for a 3rd dose and/or a booster dose of the vaccine, either because:

• they have a condition that means they’re at high risk of getting seriously ill from COVID-19 (this could be a severe problem with the brain or nerves, such as cerebral palsy; Down’s syndrome; severe or multiple learning disabilities or they’re on the learning disability register; or a condition that means they’re more likely to get infections such as some genetic conditions or types of cancer

or

• they live with someone who is more likely to get infections (such as someone who has HIV, has had a transplant or is having certain treatments such as for cancer, lupus or rheumatoid arthritis).

For more information on the booster dose for 12 to 15 year olds, visit the NHS website.

Why should a child get the COVID-19 vaccine?

Getting the vaccine will help to protect children and young people against COVID-19. Whilst most children usually have mild illness, they can pass on their infection to others in their family and those they come into contact with. Further information is available online at bit.ly/children-guide.

Is there a risk of a child having an allergic reaction to the vaccine?

As part of the process, every child will be taken through a set of screening questions designed to pick up any conditions that may need special consideration before vaccination. Before any vaccination appointment, it would be helpful for children and their parents to consider what is likely to be asked, and some pre-screening questions to help do this are available online at bit.ly/vaccine-checklist.

Will a child be able to book a COVID-19 vaccine if they are within a few weeks of their twelfth birthday?

No children under the age of 12 can receive a COVID-19 vaccination. The only vaccine legally licensed for children is for those aged 12 and above, meaning that only children who are 12 on or before the date of vaccination can be vaccinated.

Is the vaccine at local NBS and walk-in sites the same as the one offered in schools?

Yes, there is one vaccine licensed in the UK for school-aged children (Pfizer-BioNTech) and it will be exactly the same in schools or at local NHS services.

Parents and those with parental responsibilities are strongly encouraged to attend vaccine appointments with their child to go through consent and screening questions on site (in line with the approach set out in the Green Book). If the parent is not present and the child is not deemed to be able to consent, it is likely that the child will be asked to come back with a parent or guardian at a later date.

Some children may be sufficiently mature to provide their own consent if they express a wish to have a vaccine. Trained professionals with expertise in vaccinating children and assessing consent will speak to the child to assess intelligence, competence and understanding to appreciate fully what’s involved, to determine appropriateness of administering the vaccine.

For vaccinations in schools, a consent form will continue to be provided in advance and should be returned before the session.

Pre-consenting materials, including a copy of a patient information leaflet with factual information about the COVID-19 vaccine, have been shared with families along with the letters inviting them to book an appointment. Further information can be found at www.gov.uk/government/publications/covid-19-vaccination-resources-for-schools and www.gov.uk/government/publications/covid-19-vaccination-resources-for-children-and-young-people, and a consent form is at www.gov.uk/government/publications//covid-19-vaccination-consent-form-for-children-and-young-people-or-parents.

If a child gets the COVID-19 vaccine, does this mean they are protected against flu as well?

No – they are two separate vaccinations and a child would need to get both for maximum protection.

But the good news is that it has never been easier to get the flu jab – this year, the school aged flu vaccine has also been extended so that as well as children in primary school and year 7, it will now be offered to those in years 8 to 11. 

So most secondary school aged children will be eligible for both flu and COVID-19 vaccinations this winter, to protect themselves and those around them. We hope that as many as possible will come forward to get both vaccinations when they are invited. 

What is the role of schools?

Schools continue to have a really important role in the vaccination of school-aged children against COVID-19. They will continue to provide information on which children on their roll are eligible for the vaccine, to provide a venue for vaccination to take place, and to share information about the vaccine, helping children and their parents to understand the benefits and effects of the vaccine.

Are vaccines safe for children?

On 4 June 2021, the UK’s independent medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), concluded a positive safety profile for the Pfizer-BioNTech vaccine in children aged 12-15.

This follows a stringent and rigorous review of the safety, quality, and effectiveness of the vaccine in this age group by the MHRA and the Government’s expert independent advisory body, the Commission on Human Medicines.

What information is available about the COVID-19 booster for people with learning disabilities?